Deutsche Bank’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-131,400
Closed -$10.5M 3755
2026
Q1
$10.5M Buy
+131,400
New +$10.8M ﹤0.01% 1035
2018
Q1
Sell
-750
Closed -$28K 5461
2017
Q4
$28K Buy
+750
New +$27.5K ﹤0.01% 4592

Other funds holding EW

Deutsche Bank's EW Position: Q2 2026 in Review

Deutsche Bank reduced its Edwards Lifesciences (EW) stake by 5.7% in Q2 2026, selling an estimated $28.9M and leaving 5,710,284 shares worth $517M. The position accounts for 0.15% of the portfolio, ranked #132.

Deutsche Bank first reported a position in EW in Q2 2013 and has held it in 53 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Deutsche Bank held 5,710,284 shares of Edwards Lifesciences worth $517M as of Q2 2026.
  • Deutsche Bank sold 344,739 Edwards Lifesciences shares in Q2 2026, an estimated $28.9M.
  • Edwards Lifesciences made up 0.15% of Deutsche Bank's portfolio in Q2 2026, its #132 holding.
  • Deutsche Bank first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.